361 related articles for article (PubMed ID: 9811510)
1. Surveillance for transfusion-transmitted viral infections in the United States.
Chamberland ME
Biologicals; 1998 Jun; 26(2):85-8. PubMed ID: 9811510
[TBL] [Abstract][Full Text] [Related]
2. The significance of the blood-borne viruses: blood banking and transfusion medicine.
Sherwood WC
Dev Biol Stand; 1993; 81():25-33. PubMed ID: 8174810
[TBL] [Abstract][Full Text] [Related]
3. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
[TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum of viral infections in hemophilic patients.
Telfer MC
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1047-56. PubMed ID: 1328142
[TBL] [Abstract][Full Text] [Related]
5. Blood safety monitoring among persons with bleeding disorders--United States, May 1998-June 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Jan; 51(51-52):1152-4. PubMed ID: 12553567
[TBL] [Abstract][Full Text] [Related]
6. Transfusion-transmitted infections among multitransfused patients in Iran: a review.
Rezvan H; Abolghassemi H; Kafiabad SA
Transfus Med; 2007 Dec; 17(6):425-33. PubMed ID: 18067646
[TBL] [Abstract][Full Text] [Related]
7. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
8. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.
Angelotta C; McKoy JM; Fisher MJ; Buffie CG; Barfi K; Ramsey G; Frohlich L; Bennett CL
Vox Sang; 2007 Aug; 93(2):159-65. PubMed ID: 17683360
[TBL] [Abstract][Full Text] [Related]
9. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
[TBL] [Abstract][Full Text] [Related]
10. Preventing transfusion-transmitted infections: issues related to migrating populations and increasing world travel.
Sandler SG; Fang C
Haematologia (Budap); 1991; 24(4):197-210. PubMed ID: 1688227
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
Van der Bij AK; Coutinho RA; Van der Poel CL
Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
[TBL] [Abstract][Full Text] [Related]
13. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
14. The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion.
Kleinman SH; Glynn SA; Higgins MJ; Triulzi DJ; Smith JW; Nass CC; Garratty G; Murphy EL; LeParc GF; Schreiber GB; King MR; Chamberland ME; Nemo GJ
Transfusion; 2005 Jul; 45(7):1073-83. PubMed ID: 15987350
[TBL] [Abstract][Full Text] [Related]
15. Update: HIV-2 infection among blood and plasma donors--United States, June 1992-June 1995.
Pediatr AIDS HIV Infect; 1995 Dec; 6(6):407-9. PubMed ID: 11361466
[TBL] [Abstract][Full Text] [Related]
16. [The risk of transfusion-induced virus infection].
Mörike EM
Dtsch Med Wochenschr; 1996 Sep; 121(39):A8. PubMed ID: 8925741
[No Abstract] [Full Text] [Related]
17. Hemophilia therapy and blood-borne pathogen risk.
Knight R; Stanley S; Wong M; Dolan G
Semin Thromb Hemost; 2006 Jun; 32 Suppl 2():3-9. PubMed ID: 16804829
[TBL] [Abstract][Full Text] [Related]
18. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
Shang G; Seed CR; Wang F; Nie D; Farrugia A
Transfusion; 2007 Mar; 47(3):529-39. PubMed ID: 17319836
[TBL] [Abstract][Full Text] [Related]
19. Creutzfeldt-Jakob disease and blood products: FDA policy.
Fratantoni JC
Biologicals; 1998 Jun; 26(2):133-4. PubMed ID: 9811520
[No Abstract] [Full Text] [Related]
20. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
Ludlam CA; Turner ML
Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
